Clinical Trials in New York State

Showing 4861-4880 of 13,041 trials

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

NCT05877066

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

Dupuytren's Contracture

Endo Pharmaceuticals130 participantsStarted Jun 2023

Phoenix, Arizona, United States • Greenwich, Connecticut, United States • Temple Terrace, Florida, United States +4 more locations

TERMINATEDPhase 3105 miles

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

NCT04552899

This phase III study will evaluate the efficacy, safety and pharmacokinetics (PK) of recombinant human pentraxin-2 (rhPTX-2; PRM-151) zinpentraxin alfa, compared with placebo in participants with idiopathic pulmonary fibrosis (IPF).

Idiopathic Pulmonary Fibrosis

Hoffmann-La Roche665 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +357 more locations

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Find Trials by Condition in New York State

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

DuraSorb® in Prosthetic Breast Reconstruction

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)

BI 894999 First in Human Dose Finding Study in Advanced Malignancies

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Laser Ablation After Stereotactic Radiosurgery

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Study Using Negative Pressure to Reduce Apnea

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

OPTIMISE-CKD Drug Utilization

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies